Regulation of Regenerative Medicines: A Global Perspective
xii
Yingying Liu MSc
Associate Director
CSL Behring
Switzerland
Chapter 14
Murphy Mao, MSc
Senior Regulatory Affair Manager
CSL Behring
China
Chapter 14
Snehal Naik, PhD
Regulatory Policy and Strategy Leader
Spark Therapeutics, Inc.
US
Chapters 5 and 17
Christiane Niederlaender, PhD
Vice President, Regulatory Consulting
Parexel
UK
Chapter 11
Brett Snyder, RAC
Regulatory Affairs Manager
US
Chapter 13
Rajesh L. Thangapazham, PhD, RAC
Executive Director, Regulatory Affairs
Aruvant Sciences
US
Chapter 6
Kristin Van Goor, PhD
Senior Director
Vertex Pharmaceuticals
US
Chapters 5 and 17
Darin J. Weber, PhD
Senior Vice President Regulatory Development
ProKidney
US
Chapter 7
Stephen Westover, RAC
Associate Director, RA CMC
Athersys
US
Chapters 2 and 10
Marites T. Woon, PhD
Senior Consultant, Regulatory Affairs
Parexel
US
Chapter 6
Linxi Wu, PhD
Regulatory Project Manager
Novo Nordisk
China
Chapter 14
Tomoki Yokoyama, MSc
Regulatory CMC Specialist
CSL Behring K.K.
Japan
Chapter 13
Aileen J. Zhou, MSc, PhD
Senior Manager, Regulatory Affairs
CCRM
Canada
Chapter 12
Andrea Zobel, PhD
Senior Director Personalized Supply Chain
AmerisourceBergen World Courier
Germany
Chapter 9
RAPS also recognizes the lead editors for their
strategic vision, countless hours, and unwavering
commitment to this book.
Jocelyn Jennings, MS, RAC (US, Drugs, Devices)
VP, Regulatory Affairs and Quality Assurance
Mycovia Pharmaceuticals, Inc.
US
Introduction, Chapter 4
William Sietsema, PhD
Vice President, Global Regulatory Affairs
Caladrius Biosciences
US
Preface, Chapter 10